Expression of syndecan-1 and E-cadherin is inversely correlated with poor patient's prognosis and recurrent status of extrahepatic bile duct carcinoma
-
- Ohashi Motonari
- Departments of Pathology and, Hirosaki University School of Medicine Departments of Surgery, Hirosaki University School of Medicine
-
- Kusumi Tomomi
- Departments of Pathology and, Hirosaki University School of Medicine
-
- Sato Fuyuki
- Departments of Pathology and, Hirosaki University School of Medicine
-
- Kudo Yasuyuki
- Departments of Pathology and, Hirosaki University School of Medicine
-
- Jin Hiroyuki
- Departments of Pathology and, Hirosaki University School of Medicine Departments of Surgery, Hirosaki University School of Medicine
-
- Akasaka Harue
- Departments of Pathology and, Hirosaki University School of Medicine Departments of Surgery, Hirosaki University School of Medicine
-
- Miyamoto Keiichi
- Departments of Surgery, Hirosaki University School of Medicine
-
- Toyoki Yoshikazu
- Departments of Surgery, Hirosaki University School of Medicine
-
- Hakamada Kenichi
- Departments of Surgery, Hirosaki University School of Medicine
-
- Kijima Hiroshi
- Departments of Pathology and, Hirosaki University School of Medicine
Search this article
Abstract
Extrahepatic bile duct carcinoma is one of the most extremely aggressive cancers with poor prognosis after curative resection. Syndecan-1 and E-cadherin are transmembrane glycoproteins, and have important roles in cell-cell adhesion and tumor progression. In this study, we examined 84 surgically resected cases of extrahepatic bile duct adenocarcinoma to clarify clinicopathological significance of syndecan-1/E-cadherin expression. Reduced expressions of syndecan-1 and Ecadherin were found in 69.0% (58/84) and 46.4% (39/84) of the bile duct carcinomas. Reduced syndecan-1 expression was correlated with lymphatic/venous/nervous invasion (P < 0.0001), and was associated with short overall survival (P = 0.0002). Reduced E-cadherin expression was correlated with lymphatic and nervous invasion (P = 0.008, P < 0.0001, respectively), and was associated with short overall survival (P = 0.0038). The results indicated that reduced syndecan-1/E-cadherin expression may be good indicators of recurrence and prognosis in extrahepatic bile duct carcinoma.
Journal
-
- Biomedical Research
-
Biomedical Research 30 (2), 79-86, 2009
Biomedical Research Press
- Tweet
Details 詳細情報について
-
- CRID
- 1390282679878766720
-
- NII Article ID
- 130004470741
-
- ISSN
- 1880313X
- 03886107
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- Crossref
- CiNii Articles
-
- Abstract License Flag
- Disallowed